Summary: A new University of Pittsburgh study overturns a long-standing idea about teenage risk-taking. Instead of being driven by excess dopamine, early experimentation with alcohol, cannabis, nicotine and other substances appears linked to lower baseline dopamine activity. The research used a decade-long dataset and a non-invasive brain imaging proxy to show that some adolescents seek out substances as a compensatory way to stimulate an under-active reward system, and that this behavior typically declines as the dopamine system matures into adulthood.
Working with more than 800 participants tracked across up to nine years, researchers analyzed repeated behavioral assessments and annual brain scans. They used measurements of brain tissue iron in the basal ganglia as a validated structural proxy for long-term dopamine content, enabling safe, longitudinal study of dopamine-related neurobiology. This approach identified a distinct “youth peak” trajectory: teens with the lowest baseline reward biology who showed a sharp spike in substance experimentation in early adolescence followed by a steep decline by their mid-twenties.
Key Facts
- The Inverse Dopamine Paradigm: Contrary to previous models that attributed teenage risk-taking to an overactive dopamine system, this study finds that low baseline dopamine—an under-stimulated reward circuit—can drive early substance seeking as a form of biological compensation.
- Clear “Youth Peak” Trajectory: Using growth mixture modeling on more than 6,000 repeated assessments, researchers identified distinct substance use patterns. Roughly one in four adolescents fit a youth-peak pattern: early experimentation followed by a drop in use during the mid-twenties.
- Brain Iron as a Dopamine Proxy: Measuring tissue iron in deep subcortical regions provided a reliable, non-invasive indicator of dopamine-related neurobiology over time. Lower tissue iron corresponded with lower baseline dopamine proxy measures among youth in the “youth peak” group.
- Biology Precedes Use: By leveraging data from the National Consortium on Alcohol and Neurodevelopment in Adolescence and Young Adulthood (NCANDA-A), the team captured scans before substance exposure began. This showed that lower dopamine-related markers preceded, rather than resulted from, early substance experimentation.
- Natural Resolution with Maturation: As adolescents in the youth-peak group aged, their brain tissue iron (and inferred dopamine function) increased rapidly and steadily. This neurobiological maturation coincided with a large drop in substance use, suggesting that most early experimentation is a self-limited developmental phase.
- Digital Substitution Hypothesis: Although the study did not measure social media use, researchers note a cultural shift: youth substance use has declined while digital engagement has grown. Fast, highly reinforcing digital environments may offer an alternative reward channel for low-dopamine adolescent brains, a topic recommended for future research.
- Guiding the Adaptive Drive: Risk-taking is an evolutionarily conserved process that helps adolescents gain independence. Clinicians and parents are encouraged to channel that drive toward positive, high-reward activities such as team sports, creative arts, or other socially engaging outlets rather than attempting to eliminate it.
Source: University of Pittsburgh
Headline finding: Teenage risk-taking and early substance experimentation may often reflect a compensatory response to lower baseline dopamine in the reward system, according to a University of Pittsburgh School of Medicine study published in Nature Communications. The study reframes how researchers view adolescent neurodevelopment and suggests new paths for identifying which young people might benefit from additional support.
“A portion of adolescents may take risks to ‘get the system going’ when dopamine-related reward biology is low at the start of adolescence,” said lead author Ashley Parr, Ph.D., research assistant professor of psychiatry at Pitt. This contrasts with the longstanding assumption that elevated dopamine directly causes greater substance use during adolescence.
Adolescence is a highly dynamic period of brain development when many young people experiment with boundaries and new experiences. This exploration is a normal developmental process that, in most cases, helps individuals progress toward independence. In the NCANDA-A cohort, most teens who experimented did not go on to develop substance use disorders; overall substance use declined after the college years for the cohort.
Researchers combined behavioral measures of impulsivity and inhibitory control with longitudinal imaging and self-reported substance use. Across the sample, substance use and markers of neurocognitive maturation changed with age: substance use and tissue iron increased while impulsivity declined. The youth-peak trajectory was distinguished by particularly low tissue iron and higher impulsivity in early adolescence, followed by rapid neurobiological maturation and falling substance use.
“The important question is not who tries substances, but who continues and escalates into adulthood,” Parr added. Longitudinal tracking made it possible to identify early brain and behavioral markers that differentiate typical, temporary experimentation from patterns that may indicate higher long-term risk.
Key Questions Answered
A: Low baseline dopamine can leave the adolescent brain feeling under-stimulated. Risky behaviors and substance experimentation can produce strong artificial surges of chemical activity, effectively acting as a blunt mechanism to activate a sluggish reward system.
A: Brain tissue iron is a structural component that supports dopamine synthesis and maintenance in deep reward centers. Longitudinal measures of tissue iron provide a validated, non-invasive proxy for tracking dopamine-related neurobiology over time.
A: No. The study’s reassuring result is that for most adolescents, youth-peak experimentation is temporary. As the brain’s reward circuitry matures and baseline dopamine-related markers rise, the drive to seek artificial chemical rewards typically diminishes and substance use decreases.
Editorial Notes
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by editorial staff for clarity.
About this neuroscience and neurodevelopment research news
Author: Anastasia Gorelova
Source: University of Pittsburgh
Contact: Anastasia Gorelova – University of Pittsburgh
Image credit: Neuroscience News
Original Research: Open access. “Developmental variation in basal ganglia tissue iron, neurocognitive functioning, and impulsivity is associated with substance use trajectories in youth” by Ashley C. Parr et al., Nature Communications. DOI: 10.1038/s41467-026-73611-1
Abstract
Developmental variation in basal ganglia tissue iron, neurocognitive functioning, and impulsivity is associated with substance use trajectories in youth
Neurodevelopmental models implicate dopamine-related and neurocognitive maturation in adolescent risk-taking, but their combined contribution to substance use patterns in humans has been unclear. In the NCANDA-A cohort (N = 802; ages 12–30; 6,078 visits), researchers examined basal ganglia tissue iron alongside measures of impulsivity and inhibitory control to relate neurobiology and cognition to longitudinal substance use trajectories.
Growth mixture models identified four primary trajectories: no/low use (30%), youth peak (26%), adolescent increasing (17%), and adult increasing (26%). Across participants, substance use and tissue iron increased with age while impulsivity declined. Greater substance use was associated with higher impulsivity, poorer inhibitory control, and lower tissue iron, especially in early adolescence among youth-peak patterns. Trajectories differed according to the timing and rate of maturation in both impulsivity and tissue iron.
These results suggest that developmental variation in tissue iron and neurocognitive maturation contribute to youth substance use, highlighting adolescence as a sensitive window for risk stratification and prevention efforts.